General MedicationsORALStandard

PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE

GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

Standard Dose

2MG;30MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is listed in Drugs@FDA under application 201049 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE Form and strength TABLET;ORAL - 2MG;30MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-02-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE is listed in Drugs@FDA under application 201049 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE Form and strength TABLET;ORAL - 2MG;30MG Sponsor CHARTWELL RX Submission history Latest submission status date: 2020-02-24 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.